News

Latest news
November 20, 2026

AbbVie (NYSE: ABBV) will participate in the Piper Sandler 38th Annual Healthcare Conference on Wednesday, December 2, 2026. Management will participate in a fireside chat at 7:30 a.m. Central...

November 19, 2026

Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade This...

November 08, 2026

– HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported...

More »

AbbVie on

Looking for more news from AbbVie? Follow us on social media.

News

Advanced Search
Show 5102550100 per page
Who we are

Get to know the passionate people who make up AbbVie and the difference we strive to make, one patient at a time. Learn more

Sustainability

Our commitment to science is a commitment to better our society. Read our 2025 ESG report

Key Facts

Get a closer look at our impact. 
Learn more

Annual report

See our latest 2025 Annual Report on Form 10-K. Learn more

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?